Abstract

Currently, thyroid cancer and benign thyroid conditions are both often treated with complete thyroidectomy. It is still debatable how to distinguish between benign and malignant thyroid conditions and whether or not thyroid micro carcinomas may be detected using biochemical markers. The objective of this retrospective study was to assess the predictive value of thyroid autoantibodies, thyroglobulin, and thyroid disease type in diagnostic techniques regarding the co-existence of incidental thyroid cancer with benign thyroid illnesses. Methods. Between 2005 and 2010, 228 individuals with benign thyroid diseases had TT treatment. TG and thyroid autoantibodies were calculated before surgery [1]. The median values of the biochemical markers were compared between the groups after patients were divided into groups based on their preoperative and histologically confirmed diagnosis [2].